213 related articles for article (PubMed ID: 31813050)
1. Deep neural network for automatic characterization of lesions on
Zhao Y; Gafita A; Vollnberg B; Tetteh G; Haupt F; Afshar-Oromieh A; Menze B; Eiber M; Rominger A; Shi K
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):603-613. PubMed ID: 31813050
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-based whole-body characterization of prostate cancer lesions on [
Huang B; Yang Q; Li X; Wu Y; Liu Z; Pan Z; Zhong S; Song S; Zuo C
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1173-1184. PubMed ID: 38049657
[TBL] [Abstract][Full Text] [Related]
3. Deep Neural Network for Automatic Characterization of Lesions on 68Ga-PSMA PET/CT Images.
Zhao Y; Gafita A; Tetteh G; Haupt F; Afshar-Oromieh A; Menze B; Eiber M; Rominger A; Shi K
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():951-954. PubMed ID: 31946051
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. A convolutional neural network-based system for fully automatic segmentation of whole-body [
Jafari E; Zarei A; Dadgar H; Keshavarz A; Manafi-Farid R; Rostami H; Assadi M
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1476-1487. PubMed ID: 38095671
[TBL] [Abstract][Full Text] [Related]
6. Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss.
Xu Y; Klyuzhin I; Harsini S; Ortiz A; Zhang S; Bénard F; Dodhia R; Uribe CF; Rahmim A; Lavista Ferres J
Comput Biol Med; 2023 May; 158():106882. PubMed ID: 37037147
[TBL] [Abstract][Full Text] [Related]
7. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [
Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
10. (68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.
Sachpekidis C; Eder M; Kopka K; Mier W; Hadaschik BA; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1288-99. PubMed ID: 26753602
[TBL] [Abstract][Full Text] [Related]
11. Early dynamic imaging in
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
[TBL] [Abstract][Full Text] [Related]
12. Optimal time-point for
Beheshti M; Paymani Z; Brilhante J; Geinitz H; Gehring D; Leopoldseder T; Wouters L; Pirich C; Loidl W; Langsteger W
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1188-1196. PubMed ID: 29476228
[TBL] [Abstract][Full Text] [Related]
13. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
Uprimny C; Kroiss AS; Fritz J; Decristoforo C; Kendler D; von Guggenberg E; Nilica B; Maffey-Steffan J; di Santo G; Bektic J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1647-1655. PubMed ID: 28589253
[TBL] [Abstract][Full Text] [Related]
14. Automated segmentation of lesions and organs at risk on [
Yazdani E; Karamzadeh-Ziarati N; Cheshmi SS; Sadeghi M; Geramifar P; Vosoughi H; Jahromi MK; Kheradpisheh SR
Cancer Imaging; 2024 Feb; 24(1):30. PubMed ID: 38424612
[TBL] [Abstract][Full Text] [Related]
15. Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.
Pfister D; Porres D; Heidenreich A; Heidegger I; Knuechel R; Steib F; Behrendt FF; Verburg FA
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1410-7. PubMed ID: 26993315
[TBL] [Abstract][Full Text] [Related]
16.
Calais J; Czernin J; Cao M; Kishan AU; Hegde JV; Shaverdian N; Sandler K; Chu FI; King CR; Steinberg ML; Rauscher I; Schmidt-Hegemann NS; Poeppel T; Hetkamp P; Ceci F; Herrmann K; Fendler WP; Eiber M; Nickols NG
J Nucl Med; 2018 Feb; 59(2):230-237. PubMed ID: 29123013
[TBL] [Abstract][Full Text] [Related]
17.
Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716
[TBL] [Abstract][Full Text] [Related]
18. Comparison of
Schwenck J; Rempp H; Reischl G; Kruck S; Stenzl A; Nikolaou K; Pfannenberg C; la Fougère C
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):92-101. PubMed ID: 27557844
[TBL] [Abstract][Full Text] [Related]
19. Potential Impact of
Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG
J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978
[TBL] [Abstract][Full Text] [Related]
20. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [
Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JSL; Ebert MA
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):67-79. PubMed ID: 35976392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
